Sign In
Buy ARQT
$21.35
+0.560 (+2.69%)
At Close: Jun 03, 2026
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Wednesday, 05'th Jun 2024
WESTLAKE VILLAGE, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in
Are Medical Stocks Lagging Arcutis Biotherapeutics (ARQT) This Year?
10:41am, Friday, 31'st May 2024
Here is how Arcutis Biotherapeutics, Inc. (ARQT) and Canopy Growth Corporation (CGC) have performed compared to their sector so far this year.
Wall Street Analysts Believe Arcutis Biotherapeutics (ARQT) Could Rally 101.09%: Here's is How to Trade
10:56am, Monday, 20'th May 2024
The consensus price target hints at a 101.1% upside potential for Arcutis Biotherapeutics (ARQT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in e
Arcutis Biotherapeutics, Inc. (ARQT) Q1 2024 Earnings Call Transcript
07:47pm, Tuesday, 14'th May 2024
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT ) Q1 2024 Earnings Conference Call May 14, 2024 4:30 PM ET Company Participants Latha Vairavan - Vice President, Finance and Head of Investor Relations Frank
Arcutis Announces First Quarter 2024 Financial Results and Provides Business Update
04:00pm, Tuesday, 14'th May 2024
First quarter net product revenues for ZORYVE® franchise of $21.6M, with $15M for ZORYVE (roflumilast) cream 0.3%, and $6.5M for ZORYVE (roflumilast) topical foam, 0.3%; sales growth of 675% vs. Q1 '
Cheap Stocks To Buy: Is It Time To Buy This Ship Transport Leader?
08:45pm, Monday, 13'th May 2024
Banco BBVA has now made two tests of this key technical level in nearly three weeks.
Cheap Stocks To Buy: Should You Watch These 5 Growth Stocks? Gold Mining Play Aris Breaks Out
08:45pm, Monday, 13'th May 2024
Japan's Mitsubishi UFJ also ranks highly within IBD's Banks-Money Center industry group.
Cheap Stocks To Buy: Should You Watch These 5 Growth Stocks? Bitcoin Miner Aims At Breakout
08:45pm, Monday, 13'th May 2024
The 5% buy zone past the breakout point in Bitfarms goes up to 3.74.
Cheap Stocks To Buy: Should You Watch These 5 Growth Stocks? Cipher Mining Works On A New Base
08:45pm, Monday, 13'th May 2024
Heritage shares have cut through that price resistance like a hot knife through butter.
Cheap Stocks To Buy: Should You Watch These 5 Growth Stocks? Gold Mining Play Aris Hits 20% Profit Zone
08:45pm, Monday, 13'th May 2024
The proper buy zone from Aris Mining's breakout point goes up to 5% past 3.54, or 3.72.
Cheap Stocks To Buy: Should You Watch These 5 Growth Stocks?
08:45pm, Monday, 13'th May 2024
Arcos Dorados has broken out past resistance at 8 after forming two bases over the past 12 months. The post Cheap Stocks To Buy: Should You Watch These 5 Growth Stocks?
Cheap Stocks To Buy: Should You Watch These 5 Growth Stocks? Teekay Thrives In New Breakout Attempt
08:45pm, Monday, 13'th May 2024
Watch to see if Teekay stock can catapult past the prior entry of 7.67, or form yet another base.
Eight of nine experts expressed feeling “extremely confident” about prescribing ZORYVE foam to patients of diverse skin and hair types, including individuals with previous hair treatments, based o
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Friday, 03'rd May 2024
WESTLAKE VILLAGE, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in
Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
04:00pm, Monday, 29'th Apr 2024
WESTLAKE VILLAGE, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in
